- Home
- PHAR vs IQI Comparison
PHAR vs IQI Comparison
Compare PHAR & IQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- IQI
- Stock Information
- Founded
- PHAR 1988
- IQI 1992
- Country
- PHAR Netherlands
- IQI United States
- Employees
- PHAR N/A
- IQI N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- IQI Finance Companies
- Sector
- PHAR Health Care
- IQI Finance
- Exchange
- PHAR Nasdaq
- IQI Nasdaq
- Market Cap
- PHAR 587.5M
- IQI 529.4M
- IPO Year
- PHAR N/A
- IQI N/A
- Fundamental
- Price
- PHAR $8.37
- IQI $9.68
- Analyst Decision
- PHAR Strong Buy
- IQI
- Analyst Count
- PHAR 3
- IQI 0
- Target Price
- PHAR $30.00
- IQI N/A
- AVG Volume (30 Days)
- PHAR 7.9K
- IQI 162.1K
- Earning Date
- PHAR 03-13-2025
- IQI 01-01-0001
- Dividend Yield
- PHAR N/A
- IQI 4.61%
- EPS Growth
- PHAR N/A
- IQI N/A
- EPS
- PHAR N/A
- IQI N/A
- Revenue
- PHAR $297,200,000.00
- IQI N/A
- Revenue This Year
- PHAR $8.26
- IQI N/A
- Revenue Next Year
- PHAR $9.73
- IQI N/A
- P/E Ratio
- PHAR N/A
- IQI N/A
- Revenue Growth
- PHAR 21.15
- IQI N/A
- 52 Week Low
- PHAR $6.65
- IQI $8.05
- 52 Week High
- PHAR $11.30
- IQI $10.00
- Technical
- Relative Strength Index (RSI)
- PHAR 42.39
- IQI 37.78
- Support Level
- PHAR $8.03
- IQI $9.58
- Resistance Level
- PHAR $8.85
- IQI $9.86
- Average True Range (ATR)
- PHAR 0.33
- IQI 0.08
- MACD
- PHAR -0.00
- IQI -0.02
- Stochastic Oscillator
- PHAR 39.67
- IQI 22.60
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About IQI Invesco Quality Municipal Income Trust
Invesco Quality Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide current income which is exempt from federal income tax.